| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.22 | 5e-09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.29 | 2e-08 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |